Advertisement
Review Article| Volume 21, ISSUE 4, P825-839, October 2005

Botulinum Toxin

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Arnon S.S.
        • Schechter R.
        • Inglesby T.V.
        • et al.
        Botulism toxin as a biological weapon: medical and public health management.
        JAMA. 2001; 285: 1059-1070
        • Caya J.G.
        • Agni R.
        • Miller J.E.
        Clostridium botulinum and the clinical laboratorian: a detailed review, including biologic warfare ramifications of Botulinum toxin.
        Arch Path Lab Med. 2004; 128: 653-662
        • Middlebrook J.L.
        • Franz D.R.
        Botulinum toxins.
        in: Sidell F.R. Takafuji E.T. Franz D.R. Medical aspects of chemical and biological warfare. Office of the Surgeon General, Dept of the Army, Washington (DC)1997: 643-654
        • Zilinskas R.A.
        Iraq's biological weapons: the past as future?.
        JAMA. 1997; 278: 418-424
        • Sobel J.
        • Tucker N.
        • Sulka A.
        • et al.
        Food borne botulism in the United States, 1990–2000.
        Emerg Infect Dis. 2004; 10: 1606-1611
        • Shapiro R.L.
        • Hatheway C.
        • Swerdlow D.L.
        Botulism in the United States: a clinical and epidemiologic review.
        Ann Intern Med. 1998; 129: 221-228
        • Hughes J.M.
        • Blumenthal J.R.
        • Merson M.H.
        • et al.
        Clinical features of types A and B food-borne botulism.
        Ann Intern Med. 1981; 95: 442-445
        • Barrett D.H.
        Endemic food-borne botulism: clinical experience, 1973–1986 at Alaska Native Medical Center.
        Alaska Med. 1991; 33: 101-108
        • Schechter R.
        • Arnon S.S.
        Where Marco Polo meets Meckel: type E botulism from Clostridium butyricum.
        Clin Infect Dis. 1999; 29: 1388-1393
        • Richardson W.H.
        • Frei S.S.
        • Williams S.R.
        Case of type F botulism in southern California.
        J Toxicol Clin Toxicol. 2004; 42: 383-387
        • St. Louis M.E.
        • Peck S.H.S.
        • Bowering D.
        • et al.
        Botulism from chopped garlic: delayed recognition of a major outbreak.
        Ann Intern Med. 1988; 108: 363-368
        • Angulo F.J.
        • Getz J.
        • Taylor J.P.
        • et al.
        A large outbreak of botulism: the hazardous baked potato.
        J Infect Dis. 1998; 178: 172-177
        • Merson M.H.
        • Hughes J.M.
        • Dowell V.R.
        • et al.
        Current trends in botulism in the United States.
        JAMA. 1974; 229: 1305-1308
        • Merson M.H.
        • Dowell V.R.
        Epidemiologic, clinical, and laboratory aspects of wound botulism.
        New Eng J Med. 1973; 289: 1005-1010
        • Keller M.A.
        • Miller V.H.
        • Berkowitz C.D.
        • et al.
        Wound botulism in pediatrics.
        Am J Dis Child. 1982; 136: 320-322
        • Burningham M.D.
        • Walter F.G.
        • Mechem C.
        • et al.
        Wound botulism.
        Ann Emerg Med. 1994; 24: 1184-1187
        • Werner S.B.
        • Passaro D.
        • McGee J.
        • et al.
        Wound botulism in California, 1951–1998: recent epidemic in heroin injectors.
        Clin Infect Dis. 2000; 31: 1018-1024
        • Passaro D.J.
        • Werner S.B.
        • McGee J.
        • et al.
        Wound botulism associated with black tar heroin among injecting drug users.
        JAMA. 1996; 279: 859-863
        • Horowitz B.Z.
        • Swensen E.
        Wound botulism associated with back tar heroin.
        JAMA. 1998; 280: 1479-1480
        • Maselli R.A.
        • Ellis W.
        • Mandler R.N.
        • et al.
        Cluster of wound botulism in California: clinical, electrophysiologic and pathologic study.
        Muscle Nerve. 1997; 20: 1284-1295
        • Spitters C.
        • Moran J.
        • Kruse D.
        • et al.
        Wound botulism among black tar heroin users – Washington, 2003.
        MMWR. 2003; 52: 885-886
        • Arnon S.S.
        • Midura T.F.
        • Clay S.A.
        • et al.
        Infant botulism: epidemiological, clinical, and laboratory aspects.
        JAMA. 1977; 237: 1946-1951
        • Reddy V.
        • Balter S.
        • Weiss D.
        • et al.
        Infant botulism – New York City, 2001–2002.
        MMWR. 2003; 52: 21-24
        • Arnon S.S.
        Infant botulism.
        in: Rudolph A.M. Hoffman J.I.E. Rudolph C.D. Rudolph's Pediatrics. 20th edition. Appleton & Lange, New York1996: 555-558
        • Arnon S.S.
        • Midura T.F.
        • Damus K.
        • et al.
        Honey and other environmental risk factors for infant botulism.
        J Pediatr. 1979; 94: 331-336
        • Bakheit A.M.O.
        • Ward C.D.
        • McLellan D.L.
        Generalized botulism-like syndrome after intramuscular injections of botulism type A: a report of two cases.
        J Neurol Neurosurg Psych. 1997; 62: 198
        • Simpson L.L.
        Identification of the major steps in botulinum toxin action.
        Annu Rev Pharmacol Toxicol. 2004; 44: 167-193
        • Montecucco C.
        • Schiavo G.
        Mechanism of action of tetanus and botulinum neurotoxins.
        Mole Micro. 1994; 13: 1-8
        • Wilcox P.G.
        • Andolfatto G.
        • Fairbarn M.S.
        • et al.
        Long-term follow-up of symptoms, pulmonary function, respiratory muscle strength, and exercise performance after botulism.
        Am Rev Respir Dis. 1989; 139: 157-163
        • Woodruff B.A.
        • Griffin P.M.
        • McCroskey L.M.
        • et al.
        Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975–1988.
        J Infect Dis. 1992; 166: 1281-1283
        • Koga M.
        • Yuki N.
        Hirata, Antecedent symptoms in Guillain-Barre syndrome: an important indicator for clinical and serological subgroups.
        Acta Neurol Scand. 2001; 103: 278-287
        • Terranova W.
        • Palumbo J.N.
        • Breman J.G.
        Ocular Findings in Botulism type B.
        JAMA. 1979; 241: 475-477
        • Ferreira J.L.
        • Eliasberg S.J.
        • Edmonds P.
        • et al.
        Comparison of the mouse bioassay and enzyme-linked immunosorbent assay procedures for the detection of Type A botulinal toxin in food.
        J Food Prot. 2004; 67: 203-206
        • Cherington M.
        Clinical spectrum of botulism.
        Muscle Nerve. 1998; 21: 701-710
        • Goldfrank L.R.
        Botulinum antitoxin.
        in: Goldfrank's Toxicologic Emergencies. 7th edition. McGraw-Hill, New York2002: 1112-1114
        • Tacket C.O.
        • Shandera W.X.
        • Mann J.M.
        • et al.
        Equine antitoxin use and other factors that predict outcome in type A food borne botulism.
        Am J Med. 1984; 76: 794-798
        • Black R.E.
        • Gunn R.A.
        Hypersensitivity reactions associated with botulinal antitoxin.
        Am J Med. 1980; 69: 567-570
        • Hatheway C.H.
        • Snyder J.D.
        • Seals J.E.
        • et al.
        Antitoxin levels in botulism patients treated with trivalent botulism antitoxin to toxin types A, B, and E.
        J Infect Dis. 1984; 150: 407-412
        • Metzger J.R.
        • Lewis L.E.
        Human-derived immune globulins for the treatment of botulism.
        Rev Infect Dis. 1979; 1: 689-692
        • Hibbs R.G.
        • Weber J.T.
        • Corwin A.
        • et al.
        Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt.
        Clin Infect Dis. 1996; 23: 337-340
        • Wilcox P.G.
        • Morrison N.J.
        • Pardy R.L.
        Recovery of the ventilatory and upper airway muscles and exercise performance after type A botulism.
        Chest. 1990; 98: 620-626
        • Horowitz B.Z.
        Polar poisons: did botulism doom the Franklin expedition?.
        J Toxicol Clin Toxicol. 2003; 41: 841-847